CLINICAL_TRIALS
safety_alert
· 2011-04-18
Clinical Trial Update: Fracture Risk With Thiazolidinediones
Summary
A clinical trial update examines fracture risk associated with thiazolidinedione therapy in type 2 diabetes, noting potential increased fracture risk with these…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Fractures, Bone, Type II Diabetes | Status: COMPLETED | Results posted: 2011-04-18